Basiliximab in Moderate to Severe Ulcerative Colitis

Mise à jour : Il y a 5 ans
Référence : NCT00430898

Femme et Homme

Extrait

The purpose of this study is to assess the safety, effectiveness and pharmacokinetics of two levels of intravenous basiliximab in ulcerative colitis, compared to placebo.


Critère d'inclusion

  • Ulcerative colitis


Liens